Exact Sciences Corporation (NASDAQ: EXAS) has reported a loss for its third fiscal quarter (ending September 30) of $-0.21 versus $0.00 for the same period a year ago. For the latest four quarters through September 30, E.P.S. were $-1.16 versus $-1.58 for the same period a year ago — a decline of -27%.
Recent Price Action
Exact Sciences Corporation (NASDAQ: EXAS) stock rose modestly by 0.5% on 11/5/24. The stock closed at $71.51. Moreover, trading volume in this advance was unusually high at 180% of normal. The stock has been strong relative to the market over the last nine months and has risen 3.1% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, EXAS is expected to be a modest Value Builder.
Exact Sciences has a current Value Trend Rating of D (Negative). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Exact Sciences has a poor Appreciation Score of 25 but a slightly positive Power Rating of 61, with the Negative Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment